1)Jatoi I, Proschan MA:Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer:a pooled analysis of updated results. Am J Clin Oncol 28:289-294, 2005
2)Fisher B, Anderson S, Bryant J, et al:Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002
3)日本乳癌学会(編):科学的根拠に基づく乳癌診療ガイドライン1.治療編.金原出版,2015
4)Kurebayashi J, Miyoshi Y, Ishikawa T, et al:Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan:Based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011. Breast Cancer 22:235-244, 2015
5)Kodama H, Nio Y, Iguchi C, et al:Ten-year follow-up results of a randomised controlled study comparing level-Ⅰ vs level-Ⅲ axillary lymph node dissection for primary breast cancer. Br J Cancer 95:811-816, 2006
6)中村清吾,津川浩一郎,岩田広治,他:センチネルリンパ節生検に対する多施設共同臨床確認試験における安全性と同定率に関する報告.乳癌の臨24:271-277,2009
7)Giuliano AE, Hunt KK, Ballman KV, et al:Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis:a randomized clinical trial. JAMA 305:569-575, 2011
8)Giuliano AE, McCall L, Beitsch P, et al:Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases:the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252:426-432;discussion 432-423, 2010
9)Donker M, van Tienhoven G, Straver ME, et al:Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer(EORTC 10981-22023 AMAROS):a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15:1303-1310, 2014
10)Galimberti V, Cole BF, Zurrida S, et al:Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases(IBCSG 23-01):a phase 3 randomised controlled trial. Lancet Oncol 14:297-305, 2013
11)Lyman GH, Temin S, Edge SB, et al:Sentinel lymph node biopsy for patients with early-stage breast cancer:American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 32:1365-1383, 2014
12)Yamashita H, Iwase H, Toyama T, et al:Estrogen receptor-positive breast cancer in Japanese women:trends in incidence, characteristics, and prognosis. Ann Oncol 22:1318-1325, 2011
13)Masuda N, Sagara Y, Kinoshita T, et al:Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer(STAGE):a double-blind, randomised phase 3 trial. Lancet Oncol 13:345-352, 2012
14)Takashima T, Mukai H, Hara F, et al:Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer(SELECT BC):an open-label, non-inferiority, randomised phase 3 trial. Lancet Oncol 17:90-98, 2016
15)Ohuchi N, Suzuki A, Sobue T, et al:Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial(J-START):a randomised controlled trial. Lancet 387:341-348, 2016